Corient Private Wealth LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 1948780 MIAMI, FL

Position in VIR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,631,444

+$1,059,411 QoQ

Shares Held

293,688

+12.7% QoQ

Ownership

0.174%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Mar 31, 2026

Corient Private Wealth LLC holds $185,550,006 across 105 Biotechnology names. VIR ranks #16 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	86,492	$38,622,137
2	IONS	Ionis Pharmaceuticals Inc	196,599	$14,762,618
3	REGN	Regeneron Pharmaceuticals, Inc.	18,073	$13,963,922
4	HALO	Halozyme Therapeutics, Inc.	190,684	$12,323,906
5	ALNY	Alnylam Pharmaceuticals, Inc.	25,718	$8,509,313
6	OMER	Omeros Corp	801,411	$8,462,900
7	RPRX	Royalty Pharma plc	116,377	$5,582,604
8	RLMD	Relmada Therapeutics, Inc.	719,582	$5,008,290

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,631,444	293,688	+12.7%	Shares	Sole	2026-05-15
2025-12-31	$1,572,033	260,702	+0.4%	Shares	Sole	2026-03-09
2025-09-30	$1,482,864	259,696	+0.1%	Shares	Sole	2025-11-14
2025-06-30	$1,307,083	259,342	+0.4%	Shares	Sole	2025-09-26
2025-03-31	$1,674,276	258,376	+0.3%	Shares	Sole	2025-05-14
2024-12-31	$1,890,196	257,520	-9.0%	Shares	Sole	2025-02-10
2024-09-30	$2,120,156	283,065	+6.4%	Shares	Sole	2024-11-12
2024-06-30	$2,368,263	266,097	-1.4%	Shares	Sole	2024-08-13
2024-03-31	$2,734,208	269,912	+1.0%	Shares	Sole	2024-05-09
2023-12-31	$2,688,826	267,279	+11.3%	Shares	Sole	2024-02-09
2023-09-30	$2,250,336	240,164	-0.3%	Shares	Sole	2023-11-03
2023-06-30	$5,911,779	241,002	+0.1%	Shares	Sole	2023-08-10
2023-03-31	$5,604,230	240,835	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.